Literature DB >> 23192871

Varicella-zoster virus ORF12 protein activates the phosphatidylinositol 3-kinase/Akt pathway to regulate cell cycle progression.

XueQiao Liu1, Jeffrey I Cohen.   

Abstract

Varicella-zoster virus (VZV) activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and alters cell cycle progression, but the viral protein(s) responsible for these activities is unknown. We previously reported that the VZV open reading frame 12 (ORF12) protein triggers phosphorylation of ERK. Here, we demonstrate that the VZV ORF12 protein also activates the PI3K/Akt pathway to regulate cell cycle progression. Transfection of cells with a plasmid expressing the ORF12 protein induced phosphorylation of Akt, which was dependent on PI3K. Infection of cells with wild-type VZV triggered phosphorylation of Akt, while infection with an ORF12 deletion mutant induced less phosphorylated Akt. The activation of Akt by ORF12 protein was associated with its binding to the p85 subunit of PI3K. Infection of cells with wild-type VZV resulted in increased levels of cyclin B1, cyclin D3, and phosphorylated glycogen synthase kinase 3β (GSK-3β), while infection with the ORF12 deletion mutant induced lower levels of these proteins. Wild-type VZV infection reduced the G(1) phase cell population and increased the M phase cell population, while infection with the ORF12 deletion mutant had a reduced effect on the G(1) and M phase populations. Inhibition of Akt activity with LY294002 reduced the G(1) and M phase differences observed in cells infected with wild-type and ORF12 mutant viruses. In conclusion, we have found that the VZV ORF12 protein activates the PI3K/Akt pathway to regulate cell cycle progression. Since VZV replicates in both dividing (e.g., keratinocytes) and nondividing (neurons) cells, the ability of the VZV ORF12 protein to regulate the cell cycle is likely important for VZV replication in various cell types in the body.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192871      PMCID: PMC3554186          DOI: 10.1128/JVI.02395-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures.

Authors:  Michael D Gober; Jennifer M Laing; Scott M Thompson; Laure Aurelian
Journal:  Brain Res       Date:  2006-10-03       Impact factor: 3.252

2.  Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Pleschka; Oliver Planz; Wiebke Beermann; Johannes G Bode; Mirco Schmolke; Stephan Ludwig
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K.

Authors:  Yeun-Kyung Shin; Qiang Liu; Suresh K Tikoo; Lorne A Babiuk; Yan Zhou
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

4.  The products of the herpes simplex virus type 1 immediate-early US1/US1.5 genes downregulate levels of S-phase-specific cyclins and facilitate virus replication in S-phase Vero cells.

Authors:  Joseph S Orlando; Todd L Astor; Scott A Rundle; Priscilla A Schaffer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Varicella-zoster virus requires a functional PI3K/Akt/GSK-3alpha/beta signaling cascade for efficient replication.

Authors:  Markus Rahaus; Nathalie Desloges; Manfred H Wolff
Journal:  Cell Signal       Date:  2006-08-24       Impact factor: 4.315

6.  The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.

Authors:  Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
Journal:  Exp Neurol       Date:  2006-10-16       Impact factor: 5.330

7.  Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence.

Authors:  Christina Ehrhardt; Henju Marjuki; Thorsten Wolff; Bernd Nürnberg; Oliver Planz; Stephan Pleschka; Stephan Ludwig
Journal:  Cell Microbiol       Date:  2006-08       Impact factor: 3.715

8.  Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

Authors:  Gen Wang; John W Barrett; Marianne Stanford; Steven J Werden; James B Johnston; Xiujuan Gao; Mei Sun; Jin Q Cheng; Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

9.  Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.

Authors:  Makoto Fukuda; Richard Longnecker
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

Review 10.  The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway.

Authors:  Nicholas J Buchkovich; Yongjun Yu; Carisa A Zampieri; James C Alwine
Journal:  Nat Rev Microbiol       Date:  2008-03-03       Impact factor: 60.633

View more
  20 in total

1.  Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus.

Authors:  Nandini Sen; Gourab Mukherjee; Adrish Sen; Sean C Bendall; Phillip Sung; Garry P Nolan; Ann M Arvin
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

Review 2.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

3.  Varicella-Zoster Virus ORF63 Protects Human Neuronal and Keratinocyte Cell Lines from Apoptosis and Changes Its Localization upon Apoptosis Induction.

Authors:  Chelsea Gerada; Megan Steain; Brian P McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

Review 4.  The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.

Authors:  XueQiao Liu; Jeffrey I Cohen
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

5.  Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion.

Authors:  Randall J Cohrs; Katherine S Lee; Addilynn Beach; Bridget Sanford; Nicholas L Baird; Christina Como; Chiharu Graybill; Dallas Jones; Eden Tekeste; Mitchell Ballard; Xiaomi Chen; David Yalacki; Seth Frietze; Kenneth Jones; Tihana Lenac Rovis; Stipan Jonjić; Jürgen Haas; Don Gilden
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

6.  ORF7 of Varicella-Zoster Virus Is Required for Viral Cytoplasmic Envelopment in Differentiated Neuronal Cells.

Authors:  Hai-Fei Jiang; Wei Wang; Xuan Jiang; Wen-Bo Zeng; Zhang-Zhou Shen; Yi-Ge Song; Hong Yang; Xi-Juan Liu; Xiao Dong; Jing Zhou; Jin-Yan Sun; Fei-Long Yu; Lin Guo; Tong Cheng; Simon Rayner; Fei Zhao; Hua Zhu; Min-Hua Luo
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

7.  The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.

Authors:  Travis Whitmer; Daniel Malouli; Luke S Uebelhoer; Victor R DeFilippis; Klaus Früh; Marieke C Verweij
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

8.  Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity.

Authors:  Heather E Eaton; Holly A Saffran; Frederick W Wu; Kevin Quach; James R Smiley
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

9.  Induction of varicella zoster virus DNA replication in dissociated human trigeminal ganglia.

Authors:  Randall J Cohrs; Hussain Badani; Nicholas L Baird; Teresa M White; Bridget Sanford; Don Gilden
Journal:  J Neurovirol       Date:  2016-09-28       Impact factor: 2.643

10.  Pseudorabies virus pUL46 induces activation of ERK1/2 and regulates herpesvirus-induced nuclear envelope breakdown.

Authors:  Katharina S Schulz; Xueqiao Liu; Barbara G Klupp; Harald Granzow; Jeffrey I Cohen; Thomas C Mettenleiter
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.